drugset / Trial / NCT06824844
The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to observe the effects of 0.05% cyclosporine eye drops combined with artificial tears on patients with diabetes-associated dry eye, and to monitor changes in ocular surface characteristics and inflammatory cytokines in tears before and after treatment.
Timeline
- Start
- 2021-12-02
- Primary completion
- 2024-03-04
- Completion
- 2024-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.05 % | Topical |